Published in Nat Rev Cancer on July 04, 2013
Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors. Nat Med (2016) 2.70
Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. Cancer Cell (2014) 2.66
LKB1 loss links serine metabolism to DNA methylation and tumorigenesis. Nature (2016) 2.11
Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1. PLoS Biol (2015) 2.07
T cell metabolism drives immunity. J Exp Med (2015) 2.06
Serine Metabolism Supports the Methionine Cycle and DNA/RNA Methylation through De Novo ATP Synthesis in Cancer Cells. Mol Cell (2016) 1.71
Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol (2015) 1.68
Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell Death Dis (2013) 1.57
MYC, Metabolism, and Cancer. Cancer Discov (2015) 1.29
mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle. Science (2016) 1.24
Genome-wide functional analysis reveals factors needed at the transition steps of induced reprogramming. Cell Rep (2014) 1.23
Characterization of the usage of the serine metabolic network in human cancer. Cell Rep (2014) 1.20
Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate. ACS Chem Biol (2014) 1.15
Histone Methylation Dynamics and Gene Regulation Occur through the Sensing of One-Carbon Metabolism. Cell Metab (2015) 1.11
Mitochondria and Cancer. Mol Cell (2016) 1.11
The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. Cell Metab (2013) 1.09
Fundamentals of cancer metabolism. Sci Adv (2016) 1.09
MYC and metabolism on the path to cancer. Semin Cell Dev Biol (2015) 1.09
Endothelial cell metabolism in normal and diseased vasculature. Circ Res (2015) 1.09
cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. Cell Res (2015) 1.06
Serine and one-carbon metabolism in cancer. Nat Rev Cancer (2016) 1.06
Metabostemness: a new cancer hallmark. Front Oncol (2014) 1.05
Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease. EMBO Mol Med (2014) 1.04
Repurposing metformin: an old drug with new tricks in its binding pockets. Biochem J (2015) 1.03
Bioinformatics analysis of the serine and glycine pathway in cancer cells. Oncotarget (2014) 1.02
Products of the Parkinson's disease-related glyoxalase DJ-1, D-lactate and glycolate, support mitochondrial membrane potential and neuronal survival. Biol Open (2014) 1.00
Genome-culture coevolution promotes rapid divergence of killer whale ecotypes. Nat Commun (2016) 0.99
Effects of palmitate on genome-wide mRNA expression and DNA methylation patterns in human pancreatic islets. BMC Med (2014) 0.98
An ancient riboswitch class in bacteria regulates purine biosynthesis and one-carbon metabolism. Mol Cell (2015) 0.98
A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat Chem Biol (2016) 0.98
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis (2015) 0.95
Metabolic control of epigenetics in cancer. Nat Rev Cancer (2016) 0.94
ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis (2016) 0.94
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer (2016) 0.93
Arsenic exposure, arsenic metabolism, and incident diabetes in the strong heart study. Diabetes Care (2015) 0.93
Genome-wide meta-analysis of homocysteine and methionine metabolism identifies five one carbon metabolism loci and a novel association of ALDH1L1 with ischemic stroke. PLoS Genet (2014) 0.93
DNMT1-associated long non-coding RNAs regulate global gene expression and DNA methylation in colon cancer. Hum Mol Genet (2015) 0.93
Endothelial cell metabolism: parallels and divergences with cancer cell metabolism. Cancer Metab (2014) 0.92
Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice. Nat Commun (2015) 0.91
Metabolic Reprogramming of Stem Cell Epigenetics. Cell Stem Cell (2015) 0.91
The importance of serine metabolism in cancer. J Cell Biol (2016) 0.89
SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation. Cell Death Dis (2014) 0.87
KDM4C and ATF4 Cooperate in Transcriptional Control of Amino Acid Metabolism. Cell Rep (2016) 0.87
A Flux Balance of Glucose Metabolism Clarifies the Requirements of the Warburg Effect. Biophys J (2016) 0.86
Metabolic control of methylation and acetylation. Curr Opin Chem Biol (2015) 0.86
Glycolytic Metabolism Plays a Functional Role in Regulating Human Pluripotent Stem Cell State. Cell Stem Cell (2016) 0.86
Epigenetics and cancer metabolism. Cancer Lett (2013) 0.86
The Intercellular Metabolic Interplay between Tumor and Immune Cells. Front Immunol (2014) 0.86
Heterogeneity of glycolysis in cancers and therapeutic opportunities. Biochem Pharmacol (2014) 0.86
Cancer's Fuel Choice: New Flavors for a Picky Eater. Mol Cell (2015) 0.86
MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers. Comput Struct Biotechnol J (2016) 0.85
Emerging regulatory paradigms in glutathione metabolism. Adv Cancer Res (2014) 0.85
A metabolomic approach to identifying platinum resistance in ovarian cancer. J Ovarian Res (2015) 0.85
Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis? Carcinogenesis (2015) 0.85
Oncometabolites: tailoring our genes. FEBS J (2015) 0.85
Targeting folate receptor alpha for cancer treatment. Oncotarget (2016) 0.84
Arginine deprivation and autophagic cell death in cancer. Proc Natl Acad Sci U S A (2014) 0.84
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype. Oncotarget (2015) 0.84
Metabolism and epigenetics: a link cancer cells exploit. Curr Opin Biotechnol (2014) 0.84
Serine one-carbon catabolism with formate overflow. Sci Adv (2016) 0.84
One-carbon metabolism and epigenetics: understanding the specificity. Ann N Y Acad Sci (2015) 0.84
DNA Methylation in Skeletal Muscle Stem Cell Specification, Proliferation, and Differentiation. Stem Cells Int (2016) 0.84
Hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress. Cell Res (2016) 0.83
Oncometabolic Nuclear Reprogramming of Cancer Stemness. Stem Cell Reports (2016) 0.83
Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma. Oncotarget (2015) 0.83
Metal Ion-Mediated Nucleobase Recognition by the ZTP Riboswitch. Chem Biol (2015) 0.83
2-Aminoacrylate Stress Induces a Context-Dependent Glycine Requirement in ridA Strains of Salmonella enterica. J Bacteriol (2015) 0.82
An epitope tag alters phosphoglycerate dehydrogenase structure and impairs ability to support cell proliferation. Cancer Metab (2015) 0.82
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions. Cancer Discov (2016) 0.82
Metabolic control of cancer cell stemness: Lessons from iPS cells. Cell Cycle (2015) 0.81
Pyruvate Kinase Isoform Switching and Hepatic Metabolic Reprogramming by the Environmental Contaminant 2,3,7,8-Tetrachlorodibenzo-p-Dioxin. Toxicol Sci (2015) 0.81
Combining amine metabolomics and quantitative proteomics of cancer cells using derivatization with isobaric tags. Anal Chem (2014) 0.81
Quantification of folate metabolism using transient metabolic flux analysis. Cancer Metab (2015) 0.81
Targeting amino acid metabolism in cancer growth and anti-tumor immune response. World J Biol Chem (2015) 0.81
Targeting One Carbon Metabolism with an Antimetabolite Disrupts Pyrimidine Homeostasis and Induces Nucleotide Overflow. Cell Rep (2016) 0.81
Cells deficient in base-excision repair reveal cancer hallmarks originating from adjustments to genetic instability. Nucleic Acids Res (2015) 0.80
Techniques to monitor glycolysis. Methods Enzymol (2014) 0.80
Epigenetic regulation of the nuclear-coded GCAT and SHMT2 genes confers human age-associated mitochondrial respiration defects. Sci Rep (2015) 0.80
Impact of acetylation on tumor metabolism. Mol Cell Oncol (2014) 0.78
Metabolic circuits in neural stem cells. Cell Mol Life Sci (2014) 0.78
Amino acid management in cancer. Semin Cell Dev Biol (2015) 0.78
Imaging tumor metabolism using positron emission tomography. Cancer J (2015) 0.78
Methylthioadenosine (MTA) Regulates Liver Cells Proteome and Methylproteome: Implications in Liver Biology and Disease. Mol Cell Proteomics (2016) 0.78
Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program. Stem Cells (2016) 0.78
Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation. Cancer Cell Int (2016) 0.78
One-Carbon Metabolism in Health and Disease. Cell Metab (2016) 0.78
Integrative modelling of tumour DNA methylation quantifies the contribution of metabolism. Nat Commun (2016) 0.77
Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma. Sci Rep (2016) 0.77
Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis. BMC Cancer (2014) 0.77
MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radic Biol Med (2016) 0.77
Heterogeneity in Cancer Metabolism: New Concepts in an Old Field. Antioxid Redox Signal (2016) 0.77
Non-invasive metabolic imaging of brain tumours in the era of precision medicine. Nat Rev Clin Oncol (2016) 0.77
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Sci Adv (2016) 0.77
Formate supplementation enhances folate-dependent nucleotide biosynthesis and prevents spina bifida in a mouse model of folic acid-resistant neural tube defects. Biochimie (2016) 0.77
MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma. Oncotarget (2015) 0.77
miR-370 and miR-373 regulate the pathogenesis of osteoarthritis by modulating one-carbon metabolism via SHMT-2 and MECP-2, respectively. Aging Cell (2015) 0.77
From microbiology to cancer biology: the Rid protein family prevents cellular damage caused by endogenously generated reactive nitrogen species. Mol Microbiol (2015) 0.77
Metabolic rewiring in melanoma. Oncogene (2016) 0.76
Targeting MTHFD2 in acute myeloid leukemia. J Exp Med (2016) 0.76
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
The language of covalent histone modifications. Nature (2000) 44.92
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med (2004) 41.02
The landscape of somatic copy-number alteration across human cancers. Nature (2010) 31.88
The epigenomics of cancer. Cell (2007) 30.91
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol (2010) 21.16
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature (2009) 19.65
The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab (2008) 18.87
Genome maintenance mechanisms for preventing cancer. Nature (2001) 16.17
Mutation in TET2 in myeloid cancers. N Engl J Med (2009) 16.07
Regulation of cancer cell metabolism. Nat Rev Cancer (2011) 15.44
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell (2010) 15.20
The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell (1996) 15.19
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature (2010) 14.50
DNMT3A mutations in acute myeloid leukemia. N Engl J Med (2010) 14.07
The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol (2005) 12.70
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature (2009) 12.58
Epigenetics in human disease and prospects for epigenetic therapy. Nature (2004) 11.46
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol (2003) 11.22
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science (2010) 10.78
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov (2009) 10.32
Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell (2012) 9.88
Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer (2011) 9.68
Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev (2001) 9.54
The role of DNA methylation in mammalian epigenetics. Science (2001) 9.26
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer (2009) 8.43
Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli. Nat Chem Biol (2009) 8.36
Epigenetics: a landscape takes shape. Cell (2007) 8.29
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature (2011) 8.03
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93
Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev (2008) 7.87
Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. Cell (2012) 6.99
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet (2011) 6.89
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science (2012) 6.79
Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov (2006) 6.39
Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer (2010) 6.27
Cancer epigenetics reaches mainstream oncology. Nat Med (2011) 5.83
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene (2009) 5.81
Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov (2011) 5.79
Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell (2011) 4.83
Translational control in cancer. Nat Rev Cancer (2010) 4.59
Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med (1998) 4.40
Timeline: Chemotherapy and the war on cancer. Nat Rev Cancer (2005) 4.16
Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol (2010) 4.11
Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology (2007) 4.06
Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer (2009) 3.99
Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell (2012) 3.92
Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell (2012) 3.82
How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature (2012) 3.77
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature (2012) 3.77
S-Adenosylmethionine and methylation. FASEB J (1996) 3.48
Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov (2007) 3.46
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature (2011) 3.37
Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res (1997) 3.36
Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst (1993) 3.25
Absolute quantitation of intracellular metabolite concentrations by an isotope ratio-based approach. Nat Protoc (2008) 3.24
Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res (1999) 3.23
Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell (2013) 3.10
Methionine metabolism in mammals. J Nutr Biochem (1990) 3.06
Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature (2012) 3.01
Hypusine-containing protein eIF5A promotes translation elongation. Nature (2009) 2.99
Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science (2012) 2.98
Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol (2004) 2.95
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J Clin Oncol (2001) 2.87
Choline metabolism in malignant transformation. Nat Rev Cancer (2011) 2.85
Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr (2004) 2.83
Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N Engl J Med (1948) 2.81
Membrane lipid composition and cellular function. J Lipid Res (1985) 2.71
Metformin: taking away the candy for cancer? Eur J Cancer (2010) 2.68
Influence of metabolism on epigenetics and disease. Cell (2013) 2.64
Chromatin remodeling and cancer, Part I: Covalent histone modifications. Trends Mol Med (2007) 2.60
H₂S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol (2012) 2.59
Modulation of cellular function by polyamines. Int J Biochem Cell Biol (2009) 2.59
Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol (1995) 2.57
Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem Sci (1990) 2.56
Protein arginine methyltransferases and cancer. Nat Rev Cancer (2012) 2.56
The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev (2009) 2.54
Fluorouracil: biochemistry and pharmacology. J Clin Oncol (1988) 2.46
DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst (2005) 2.43
Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis. Breast Cancer Res Treat (2010) 2.40
Dependence of mouse embryonic stem cells on threonine catabolism. Science (2009) 2.40
Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell (2012) 2.39
Physiology of folate and vitamin B12 in health and disease. Nutr Rev (2004) 2.39
The FHIT gene 3p14.2 is abnormal in lung cancer. Cell (1996) 2.36
Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci U S A (1997) 2.36
Enzymes of serine metabolism in normal, developing and neoplastic rat tissues. Adv Enzyme Regul (1984) 2.35
In vivo residue-specific histone methylation dynamics. J Biol Chem (2009) 2.33
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev (2013) 2.31
Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. J Clin Oncol (2002) 2.28
Therapeutic targets in cancer cell metabolism and autophagy. Nat Biotechnol (2012) 2.27
Metabolic flux and the regulation of mammalian cell growth. Cell Metab (2011) 2.27
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol (1998) 2.26
Folic acid supplements in pregnancy and severe language delay in children. JAMA (2011) 2.18
Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet (1989) 2.15
Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids (2009) 2.13
The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A). J Biochem (2006) 2.12
Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci U S A (2012) 2.10
Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis. Arthritis Rheum (2006) 2.09